Ginkgo Bioworks Holdings Inc Class (DNA)
CapEx to Revenue
12.99%
Quarterly · Period ending:
DNA CapEx to Revenue
Latest reported12.99%period ending
Latest reported12.99%period ending
DNA Quarterly CapEx/Revenue (15.52% → 12.99%)
Latest values, visible window
High-resolution chart · PNG
DNA capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 12.9936% | |
| 9.9261% | |
| 45.8887% | |
| 0% | |
| 0.0766% | |
| 15.7747% | |
| 31.2678% | |
| 16.9452% | |
| 48.0945% | |
| 17.684% | |
| 9.9151% | |
| 7.9037% | |
| 16.797% | |
| 24.0899% | |
| 26.0925% | |
| 20.2913% | |
| 6.6195% | |
| 2.1258% | |
| 3.4439% | |
| 7.0068% | |
| 55.0784% | |
| 49.7426% | |
| 60.5559% | |
| 215.5089% | |
| 63.5836% | |
| 15.5153% |